Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Genus Pharmaceuticals Limited, T/A Genus Pharmaceuticals, Linthwaite, Huddersfield, HD7 5QH, UK
Zinamide Tablets 500mg.
| Pharmaceutical Form |
|---|
|
White tablets, with one side scored and marked ‘GP 504’. |
Each tablet of ‘Zinamide’ contains 500 mg of pyrazinamide Ph Eur.
Excipients with known effect: Each tablet of ‘Zinamide’ contains 150.6 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pyrazinamide |
Pyrazinamide exhibits tuberculostatic activity. Pyrazinamide is active only at an acid pH, and it is therefore active mainly on the tubercle bacilli located within the cell. |
| List of Excipients |
|---|
|
Lactose |
Amber glass bottles or HDPE bottles containing 100 tablets and PVC/Al blister packs containing 30 or 60 tablets.
Not all pack sizes may be marketed.
Genus Pharmaceuticals Limited, T/A Genus Pharmaceuticals, Linthwaite, Huddersfield, HD7 5QH, UK
PL 06831/0206
Date of first authorisation: 12 October 2007
Date of latest renewal: 13 February 2009
| Drug | Countries | |
|---|---|---|
| ZINAMIDE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
